Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-025332
Filing Date
2019-05-10
Accepted
2019-05-10 17:11:49
Documents
72
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv520575_10q.htm 10-Q 786578
2 EXHIBIT 31.1 tv520575_ex31-1.htm EX-31.1 10952
3 EXHIBIT 31.2 tv520575_ex31-2.htm EX-31.2 11046
4 EXHIBIT 32.1 tv520575_ex32-1.htm EX-32.1 5295
5 EXHIBIT 32.2 tv520575_ex32-2.htm EX-32.2 5401
  Complete submission text file 0001144204-19-025332.txt   8903350

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ibio-20190331.xml EX-101.INS 2893625
7 XBRL TAXONOMY EXTENSION SCHEMA ibio-20190331.xsd EX-101.SCH 45986
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ibio-20190331_cal.xml EX-101.CAL 37668
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ibio-20190331_def.xml EX-101.DEF 358458
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ibio-20190331_lab.xml EX-101.LAB 356115
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ibio-20190331_pre.xml EX-101.PRE 400058
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35023 | Film No.: 19815933
SIC: 2834 Pharmaceutical Preparations